✓ No active regulatory warningsFDA MedWatch, EMA EudraVigilance, WHO VigiBase, WADA Prohibited List · 2026-05-29
📰Read the full Echinacea evidence review on GMJ News →Complete clinical article, references and updates on news.gmj.ge. This page is the structured safety summary.⚠ Transplant/autoimmune patient taking echinacea — immunostimulation may counteract immunosuppression [1]
⚠ Patient expecting cold prevention — evidence supports treatment, not prevention [3]
⚠ Products are NOT interchangeable — species and plant part matter [3]
⚠ Start at FIRST symptom onset for best results [3]
ℹ️ Not obtained from food. Not applicable — this is not obtained from food in meaningful amounts; supplementation is the practical route.
🔬 Lab interpreter
ℹ️ No validated blood test. There is no established laboratory test to assess status or guide dosing for this ingredient. Clinical response and symptoms are the practical guide.
⚕ For professionals — confirm ranges against your local laboratory.
Clinical verdict
Echinacea may modestly reduce cold duration by 1–1.5 days — IF you use the right product (E. purpurea aerial extract) and start at the FIRST sign of symptoms. Products are NOT interchangeable. Prevention evidence is weak. Short-term use only (7–10 days). Avoid in autoimmune disease and transplant patients (immunostimulation) [1] [2] [3].
1 How much do I need?
👤 Adults: Specific dosage data under clinical review
👴 Elderly: Specific dosage data under clinical review
🤰 Pregnancy: See guidance
Limited safety data. Consult physician [1].
👦 Pediatric: See guidance
Limited data. Some European products are marketed for children >4 years. Safety and efficacy not well-established [1].
🏃 Athletes: Standard dose
⚖️ Obesity: Standard dose
Fat-soluble compounds may require dose adjustment in obesity.
🩺 Renal: Consult specialist
Dose adjustment may be needed in renal impairment.
🌱 Vegan: Standard dose
How to take
🍽 Timing: At FIRST sign of cold symptoms. 3× daily for 7–10 days [3].
💊 With food: Can be taken with or without food [1].
🚫 Avoid: Autoimmune disease (immunostimulation). Immunosuppressant medications. Long-term use >8 weeks [1].
2 Which form?
| Form | Bioavailability | Vegan | Cost |
|---|---|---|---|
| ['E. purpurea aerial parts extract', 'preferred', 'Most studied. Standardized to alkamides or cichoric acid. Used in the majority of positive trials [2].'] | Standard | Check label | |
| ['E. purpurea pressed juice (Echinagard/Echinacin)', '', 'Fresh plant juice. Well-studied in European trials [2].'] | Standard | Check label | |
| ['E. angustifolia root extract', 'common', 'Root preparation. Different chemical profile. Often combined with E. purpurea [2].'] | Standard | Check label | |
| ['Dried herb/tea', '', 'Variable potency. Not standardized [1].'] | Standard | Check label |
3 Common questions
Does echinacea prevent colds? ▼
The evidence for prevention is weak and inconsistent. Echinacea works better for TREATMENT (started at symptom onset) than prevention [3]. Some products may reduce cold incidence, but you cannot reliably count on it.
Which echinacea product is best? ▼
E. purpurea aerial parts extract or pressed juice (Echinacin/Echinagard) has the most positive trial data. Products are NOT interchangeable — species, plant part, and preparation matter enormously [3]. Look for standardized products.
How quickly should I start echinacea? ▼
At the FIRST sign of cold symptoms. The earlier you start, the better the evidence for benefit. Waiting until a cold is fully established reduces or eliminates benefit [3].
Is long-term echinacea safe? ▼
Most guidelines recommend short-term use (7–10 days per cold episode). Long-term daily use (>8 weeks) is not well-studied and is theoretically concerning for autoimmune patients due to immune stimulation [1].
4 Clinical evidence
Strong
Immune modulation: echinacea activates macrophages, NK cells, and dendritic cells in vitro and in animal models [2]. Product heterogeneity: different species, plant parts, and extractions produce vastly different chemical profiles and clinical outcomes [3]. HIGH
Moderate
Common cold treatment: Cochrane review (24 trials, n=4,631) — some E. purpurea products may reduce cold duration by 1–1.5 days and severity modestly, but results are inconsistent across preparations [3]. Prevention: some trials suggest modest reduction in cold incidence with long-term use, but the evidence is NOT consistent [3]. MODERATE
Insufficient
5 Safety, toxicity & adverse events
Relative
⚠ Autoimmune diseases — immunostimulation may worsen symptoms
⚠ Concurrent immunosuppressants — may reduce efficacy of cyclosporine, tacrolimus
⚠ Atopic individuals — higher risk of allergic reactions (Asteraceae family cross-reactivity)
⚠ HIV/TB — theoretical concern about immune stimulation in chronic infections
⚠ Hepatotoxic medications — rare reports of echinacea-associated liver injury
🚩 Red flags
● Ragweed-allergic patient — Asteraceae cross-reactivity [1]
● Transplant patient on immunosuppressants + echinacea — reduce echinacea [1]
● Autoimmune disease patient — immunostimulation may worsen condition [1]
6 Interactions
Drug interactions
Immunosuppressants (cyclosporine, tacrolimus) Major
Mechanism: Echinacea stimulates innate immune function. Directly opposes immunosuppressive therapy. [1]
Effect: Potential reduced immunosuppression efficacy. [1]
Action: Avoid echinacea in transplant patients [1].
Supplement synergies
Zinc · 75 mg zinc/day (for cold duration)
Both support immune function during acute cold. Zinc lozenges + echinacea is a common combination [1].
Both support immune function during acute cold. Zinc lozenges + echinacea is a common combination [1].
Vitamin C · 1,000 mg/day during cold
Complementary immune support [1].
Complementary immune support [1].
7 Regulatory
United States (FDA): Dietary supplement. No drug claims [1].
Germany (Commission E): Approved for supportive therapy for colds and urinary tract infections (E. purpurea aerial parts) [2].
European Union (EMA): 'Traditional use' registration for common cold symptom relief [2].
South Korea: Available as dietary supplement.
8 US supplement products
21
on-market products containing Echinacea (NIH DSLD)
Brands carrying Echinacea (14)
Click a brand to see its Echinacea products.
9 Frequently paired with
10 Cite this page
Vancouver: Pkhakadze G. Echinacea — safety profile [Internet]. Tbilisi: PHIG; 2026 [cited 2026 Aug 31]. Available from: https://supplement.ge/ingredients/echinacea/
APA 7th: Pkhakadze, G. (2026). Echinacea — Safety profile. Public Health Institute of Georgia. https://supplement.ge/ingredients/echinacea/
📋 Editorial information
Author: Prof. G. Pkhakadze, MD, MPH, PhD
Institution: Public Health Institute of Georgia (PHIG)
Affiliation: David Tvildiani Medical University (DTMU)
First published: January 2026
Last reviewed: 2026-05-29
Next review: March 2027
References: 3 cited sources
COI: SupplementIndex receives no funding from supplement manufacturers. All content independently authored by PHIG.
Process: Systematic literature review
📄 License & reuse
Published under Creative Commons Attribution 4.0 International (CC BY 4.0). You may share and adapt for any purpose with attribution.
Pkhakadze G. "Echinacea — Safety Profile." SupplementIndex, PHIG, 2026. https://supplement.ge/ingredients/echinacea/ CC BY 4.0.
GP
Prof. G. Pkhakadze, MD, MPH, PhD
Professor of Public Health · Head of Department, DTMU
Editor-in-Chief, Georgian Medical Journal (ISSN 3088-4322)
Chair, Public Health Institute of Georgia · UEMS Public Health Section
Educational and public health purposes. CC BY 4.0. Consult your healthcare provider before starting any supplement. Corrections: info@accreditation.ge. Publisher: PHIG